Cargando…
The role of tolvaptan in pulmonary hypertension: A retrospective study
Pulmonary hypertension (PH) is a severe form of pulmonary vascular disease that can lead to right heart failure (RHF). Nearly 2-thirds of patients with PH die within 5 years. Studies suggest that a new diuretic medication, called tolvaptan (TLV), can be used to treat PH. However, there is still insu...
Autores principales: | Chen, Qiaoli, Luo, Heng, Li, Yuping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704973/ https://www.ncbi.nlm.nih.gov/pubmed/36451399 http://dx.doi.org/10.1097/MD.0000000000031587 |
Ejemplares similares
-
The efficacy of tolvaptan for heart failure in chronic kidney disease: A protocol for systematic review and meta-analysis
por: Zhu, Zhi-Yong, et al.
Publicado: (2022) -
Effects of recombinant human brain natriuretic peptide combined with tolvaptan on cardiac and renal function and serum inflammatory factors in patients with severe heart failure
por: Yang, Jing, et al.
Publicado: (2023) -
QRS-T angle as a predictor of pulmonary arterial hypertension: A review
por: Li, Bo, et al.
Publicado: (2023) -
Diffuse Pulmonary Arteriovenous Fistulas With Pulmonary Arterial Hypertension: Case Report and Review
por: Jiang, Rong, et al.
Publicado: (2016) -
Nonadherence to antihypertensive medications amongst patients with uncontrolled hypertension: A retrospective study
por: Kulkarni, Spoorthy, et al.
Publicado: (2021)